| 前收市價 | 59.14 |
| 開市 | 50.17 |
| 買盤 | 46.90 |
| 賣出價 | 51.95 |
| 拍板 | 120.00 |
| 到期日 | 2025-03-21 |
| 今日波幅 | 50.17 - 50.17 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 10 |
ZacksModerna (MRNA) Stock Outperformed Industry YTD: Here's Why
Shares of Moderna (MRNA) are being driven by encouraging pipeline updates and plans for potential product launches.
Motley FoolShould You Buy This Stock After a Regulatory Setback?
It's not uncommon for companies to face regulatory setbacks -- and It's not the end of the world.
Barrons.comCancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
The American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual meeting. Companies such as GSK, Moderna, BioNTech, Gilead, and many others will reporting their progress.
